RNA-dependent protein kinase (PKR) is crucial for the innate immune response, cell growth, proliferation, signal transduction and apoptosis. The activation process of PKR has been studied for many years and is still under debate. To obtain new insight into the mechanism of PKR activation, we solved the crystal structure of a latent mutant of the PKR kinase domain (PKR-KD) in the apo form at a resolution of 2.9 Å. The overall structure of PKR-KD is similar to previously reported structures. Structural analysis revealed a classical back-to-back dimer and a newly defined face-to-face dimer. Analytical ultracentrifugation experiments, electrostatic surface maps and the model of PKR-KD in complex with the eIF2 substrate all support that the face-to-face dimer is more reflective of PKR in solution. Our results provide new information on PKR dimerization and its activation mechanism.
Reversible phosphorylation of proteins, which is executed by kinases and phosphatases, constitutes a major form of signaling and is an essential mechanism of regulation in all living organisms. Ser/Thr protein kinases are one class of kinases and perform essential reactions in many cellular processes [1] . Double-stranded RNA-dependent protein kinase (PKR) is a Ser/Thr protein kinase that plays a key role in the innate immunity response to viral infection [2, 3] . PKR exhibits low expression levels in normal cells. When intracellular or extracellular viral particles stimulate the body's innate immune response, cells produce interferons and simultaneously upregulate PKR. Double-stranded RNA (dsRNA) elements within the viral genome can induce activation of PKR [4] . Therefore, PKR can be considered as a cellular sensor of viral contamination. The activated PKR phosphorylates the eukaryotic initiation factor 2α (eIF2α) at Ser51, which then forms a sequestered inhibitory complex with eIF2B (guanine nucleotide exchange factor), causing inhibition of viral protein translation initiation [5, 6] .
PKR consists of two functional domains (Figure 1(a) ), the N-terminal RNA-binding domain and a C-terminal kinase domain, which are bridged by an 80-residue interdomain linker [7] . The N-terminal dsRNA-binding domain (referred as dsRBD) consists of two tandem motifs for RNA recognition. The dsRBD contains a conserved αβββα fold with two α-helices that pack against a single face of a three-stranded antiparallel β-sheet. The C-terminal domain of PKR is a catalytic domain, which has a typical protein kinase structure; its N-terminal lobe is mostly β-sheet, and its C-terminal lobe is predominantly helical [8] .
The structure of PKR-KD in complex with eIF2α revealed a back-to-back dimer with the N-terminal lobes of the kinase domain as the interface. The latent PKR has been proposed to exist in a closed or autoinhibited conformation in which dsRBD interacts with the kinase domain. Upon binding dsRNA, the latent PKR is hypothesized to change its autoinhibited conformation, and the N-lobe of the kinase domain forms a dimer that promotes autophosphorylation of the activation-segment residue Thr446, thereby leading to its efficient kinase activity [9] [10] [11] [12] . Phosphorylation of Thr446 is critical for the catalytic efficiency of PKR and for specific substrate recognition [13, 14] . The self-association of PKR is important for its kinase activation. In the absence of dsRNA, auto-phosphorylation of PKR can occur in high concentrations. Moreover, isolated PKR-KD can be activated by fusion with dimerization protein tag, indicating that dimerization of the kinase domain is sufficient to activate PKR in vitro [12] . However, the conformation of latent PKR in solution defined by small-angle X-ray scattering and small-angle neutron scattering is inconsistent with the autoinhibition model and showed that intrinsically disordered regions in PKR become ordered upon RNA binding, thereby promoting PKR dimerization [15] .
To gain insight into the mechanism of PKR activation and substrate recognition, we determined the crystal structure of the catalytic domain of an inactive human PKR mutant (K296R). We propose that PKR-KD may form a face-to-face dimer to activate its downstream target.
Materials and methods

Protein expression and purification
The DNA fragment encoding PKR-KD (Homo sapiens) was amplified from a cDNA library of the HEK293 cell line and was cloned into the pET-28a vector (Novagen, USA), which has a C-terminal His6-tag. The K296R mutant was generated by the QuickChange (Stratagene, CA) method. The recombinant plasmid was transformed into Escherichia coli BL21 CodonPlus (DE3) competent cells. The resulting cells were grown to A 600 = 0.6-0.8 in LB medium containing 30 μg/mL kanamycin at 310 K and then induced by adding isopropyl β-D-1-thiogalactopyranoside (IPTG) to a final concentration of 250 μmol/L. The cells were harvested by centrifugation 16 h later. Next, the cells were resuspended in a buffer containing 500 mmol/L NaCl, 1 mg/mL lysozyme and 20 mmol/L Tris-HCl (pH 7.5), and then sonicated on ice for 3 min (with intervals of 1 s on and 3 s off). The supernatant obtained by centrifugation for 30 min at 20000 × g was used for protein purification.
The lysate was loaded directly onto a Ni-NTA column (QIAGEN, Valencia, CA), which was first equilibrated with 5 column volumes of buffer A (500 mmol/L NaCl, 20 mmol/L Tris-HCl, pH 7.5). Non-specifically bound proteins were removed by washing the column with buffer C (500 mmol/L NaCl, 20 mmol/L Tris-HCl and 150 mmol/L imidazole, pH 7.5), and the recombinant PKR-KD proteins were eluted with buffer D (500 mmol/L NaCl, 20 mmol/L TrisHCl and 500 mmol/L imidazole, pH 7.5). The proteins were then concentrated to 500 μL with Centricon filters (Millipore, Belgium) and passed over a HiLoad Superdex 200 26/60 column (GE Healthcare Bio-Sciences, Co). The purified PKR-KD was eluted with a buffer containing 500 mmol/L NaCl, 20 mmol/L Tris-HCl, 1 mmol/L EDTA and 1 mmol/L DTT, pH 7.5. The PKR-KD mutant (PKR-KD Y404H-T446D), PKR-dsRBD2-KD K296R (residues 100-551) and full-length PKR K296R were purified following the same protocol as used for PKR-KD K296R.
Crystallization and data collection
PKR-KD (30 mg/mL in 20 mmol/L Tris-HCl, 500 mmol/L NaCl, 1 mmol/L DTT and 1 mmol/L EDTA, pH 7.5) was crystallized using the sitting drop vapor diffusion method by equilibrating against a reservoir solution consisting of 100 mmol/L MES, 200 mmol/L sodium fluoride and 20% PEG-3350, pH 6.5. Crystals were grown for one week at 277 K and flash-cooled with liquid nitrogen in a reservoir solution containing 25% glycerol. The data were collected on the BL17U1 beamline of the Shanghai Synchrotron Radiation Facility (SSRF) and then processed using the software HKL2000 [16] . The crystals diffracted to 2.9 Å and belong to space group P3 1 12, with unit cell dimensions of a=b= 95.4 Å and c=122.0 Å.
Structure determination and refinement
The initial phases were obtained by molecular replacement using the PKR-KD structure from the PKR-KD/eIF2alpha/ AMP-PNP complex (PDB code: 2A19) as a model. The program PHASER [17] located two molecules in one asymmetric unit. Model building and refinement were performed using COOT [18] and PHENIX [19] . The final structure has an R crystal value of 27.9% and an R free value of 30.5%. The Ramachandran plot constructed by the program PROCHECK [20] showed that 72.3% of the residues are found in the most favored regions, 24.6% are in additionally allowed regions, 3.1% are in generously allowed regions and none of the residues are in disallowed regions. Detailed data collection and refinement statistics are summarized in Table 1 . All figures were made by the program PyMol (DeLano Scientific LLC.).
Analytical ultracentrifugation
Sedimentation velocity (SV) experiments were performed in a Beckman/Coulter XL-I analytical ultracentrifuge using double-sector or 6-channel centerpieces and sapphirine windows. Before the experiments, the proteins were changed to the same buffer (20 mmol/L Tris-HCl, 200 mmol/L NaCl and 1 mmol/L EDTA, pH 7.5) using a HiLoad Superdex 200 26/60 column (GE Healthcare Bio-Sciences, Co). Experiments were conducted at 40000 r/min. and 283 K using double-sector cells and were monitored at 280 nm, where the absorbance of the solution ranged between 0.8 and 1.2. The data were analyzed using the program SEDFIT [21] . 
Accession numbers
The atomic coordinates and structure factors for the reported crystal structures were deposited in the Protein Data Bank with accession code 3UIU for PKR-KD.
Results and discussion
Overall structure of PKR-KD
The structure of PKR-KD was solved by molecule replacement at a resolution of 2.9 Å. Two PKR-KD molecules were present in one asymmetric unit. The final model of molecules A and B consists of residues 254-336, 355-439, 451-460 and 465-541 of the total 510 residues. The overall structure of PKR-KD adopts a typical kinase domain fold with an N-terminal lobe and a larger C-terminal lobe bridged by a short hinge (Figure 1(b) ). The N-lobe of the kinase domain consists of a 5-stranded antiparallel β sheet (β1-β5), one helix α0 on the top and another helix αC. Helix αC contains the ATP-binding site (residue 273-281). The C-lobe is comprised of two pairs of antiparallel β strands (β7-β8 and β6-β9) and eight α helices (αD-αJ). Helices αH, αI and αJ are at the bottom of the whole structure. Helix αG plays a critical role in substrate recognition.
Dimeric structure of PKR-KD
PKR-KD forms a back-to-back dimer (Figure 2(a) ) by a 2-fold non-crystallographic symmetry axis and a face-toface dimer (Figure 2(b) ) by a 2-fold crystallographic symmetry axis in the crystal structure. The superimposition of the PKR-KD/eIF2alpha/AMP-PNP complex molecule onto the molecule from our back-to-back and face-to-face models gave a RMSD value of 1.32 Å for 243 Cα atoms. The buried area calculated by AREAIMOL in the CCP4 suite [22] was 1844 Å 2 for the back-to-back dimer and 1640 Å 2 for the face-to-face dimer. The interactions are mediated by the two N-lobes within the back-to-back dimer, and no interaction was observed between the two C-lobes. By contrast, interactions occurred between both the N-and C-lobes in the face-to-face dimer.
To investigate the correlation of the dimers in the crystal and in solution, we took advantage of the analytical ultracentrifugation technique. The latent mutants (K296R) of full-length PKR, PKR-dsRBD2-KD and PKR-KD all exist as monomers in solution. However, the kinase domain of the mutant mimicking PKR phosphorylation (PKR-KD K296R-Y404H-T446D) is 90% dimeric and 10% monomeric in solution, which is distinctly different from the latent forms of PKR truncations (Figure 2(c) ). These data indicate that PKR presumably exists as a monomer and the self-association is significantly increased after phosphorylation. In other words, phosphorylation promotes dimer formation. Whereas Thr446 is located on the dimeric interface of the face-to-face dimer, it is on the opposite face in the back-to-back dimer. Therefore, we speculate that the faceto-face dimer in the crystal may be more reflective of the PKR dimer in the solution.
We constructed an electrostatic surface map of PKR-KD (Figure 3) . A positively charged area composed of Lys304, Arg307 and Arg413 was found at the center of the C-lobe. The negatively charged phosphorylation group may induce a charge-charge interaction to facilitate formation of the face-to-face dimer. We superimposed the previously determined structure of the PKR-KD/eIF2 complex onto our face-to-face dimer (Figure 4) . The eIF2 molecule can interact with both monomers in the face-to-face dimer. The PKR dimer appears to be more favorable for the binding of eIF2, in accordance with PKR dimerization being necessary to carry out its biological function in vivo.
Conclusions
In summary, we report the apo crystal structure of the K296R mutant of PKR kinase domain. Structural analysis revealed a previously unobserved face-to-face dimer, which seems to be more consistent with biochemical data. Although additional activity data will need to be collected to verify the face-to-face dimer, this model provides new information on the activation process of PKR.
